Researchers are looking to lower priced reagent options as budget purse strings tighten

Carlsbad, Calif. – October 10, 2011 – Today Percepta Associates announces the launch of the 2011 Nucleic Acid Amplification Series 3 Life Science DashboardTM market research report, providing rapid access to actionable key market indicators for the nucleic acid amplification market. The 2011 Dashboard draws comparisons to…

Researchers demand wider array of antibody product offerings from preferred suppliers for proteins of interest

Carlsbad, Calif. – August 9, 2011 – Today, Percepta Associates announced the launch of the 2011 Flow Cytometry Series 1 Life Science DashboardTM market research report. This report provides rapid access to actionable key market indicators for both reagents and instruments in the flow cytometry…

The New Quantitative Immunoassay Life Science DashboardTM from Percepta Associates projects significant potential for switching primary immunoassay product suppliers

Carlsbad, Calif. – April 21, 2011 –Today, Percepta Associates announced the launch of the 2011 Quantitative Immunoassay Series 1 Life Science DashboardTM market research report. This report provides rapid access to actionable key market indicators for the immunoassays market – such…

It was a hectic close to 2010 which shows us that biotools industry is alive and healthy! Though the future economic environment for the globe remains uncertain and public funding levels for life sciences in the US may plataue of or even dip in 2011, there were several things that we noticed at Percepta that we believe will be…

Market growth shows signs of decline in several gene silencing segments surveyed. Prospective users grow.

Carlsbad, Calif. – December 12, 2010 – Today, Percepta Associates announced the launch of the 2010 Gene Silencing Series 3 Life Science DashboardTM market research report which draws comparisons to key market indicator data reported in Percepta’s 2008 Gene Silencing Dashboard. This report provides rapid…

In the recent few quarters Percepta has experienced an increase in demand for studies relating to better serving the pharmaceutical industry. The focus of the studies have varied considerably but the trend is evident. This tells us bio-tools companies are getting more serious about tailoring an offering to the drug discovery and development market that will resonate with the…

New report reveals the cell culture research market is expected to grow to nearly $600 million in 2011, but experiencing declining growth across sub segments

Carlsbad, Calif. – September 7, 2010 – Today, Percepta Associates launched its Series Three Cell Culture Life Science DashboardTM market research report. Unique to this Series are comparisons and trends based on key market indicator…

What will be the next big thing to drive growth in the bio-tools industry? Will it be epigenetics? Gene regulation is now a focus of many drug development programs within the pharmaceutical industry. The past five years have seen the genesis of many new companies dedicating their focus to products and services tailored to monitoring gene regulation by methylation,…

We hear all the time that elements of traditional molecular biology reagent portfolios have become increasingly commoditized. Dictionary.com defines commodity as “any bulk good traded in an exchange…”. By that people generally mean that the reagent is not differentiated by anything other than price. One bag of tips or tubes is the same as the next so why pay…

We see it over and over again. Large bio-tools companies are often cited in surveys by market research participants as the suppliers of research products that they don’t even sell. What is this telling us? The cynical might think it means researchers are just clicking on buttons to get to the end of the survey – and we know…